Angelini Ventures — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
.png)
HyperSpectral develops a spectral sensing and AI layer for Physical AI that interprets matter through spectral data, molecular identification, and AI architecture.
AI & Machine LearningDeep TechDefense TechHardwareAlexandria, US
Matthew Theurer(Executive Officer, Director)Lauren Stack(Executive Officer, Director)inVincent Lubsey(Executive Officer)
BoardJuan Lopez(Director)inWilliam Porteous(Director)in
Co-investorsKibo VenturesGlade Brook Capital PartnersHeal CapitalLifeX VenturesRRE VenturesZEISS Ventures
Hypervision Surgical develops an intraoperative hyperspectral imaging system that uses AI to provide real-time, contrast-free tissue characterisation during surgery.
AI & Machine LearningHealthtechMedical Devices
Co-investorsHeal CapitalHeran PartnersLifeX VenturesMeridian Health VenturesSonorcapredalpine+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.